Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 359

1.

The intersection of radiotherapy and immunotherapy: mechanisms and clinical implications.

Spiotto M, Fu YX, Weichselbaum RR.

Sci Immunol. 2016 Sep;1(3). pii: EAAG1266. doi: 10.1126/sciimmunol.aag1266.

PMID:
28018989
2.

Man's Best Friend: Utilizing Naturally Occurring Tumors in Dogs to Improve Chimeric Antigen Receptor T-cell Therapy for Human Cancers.

Mata M, Gottschalk S.

Mol Ther. 2016 Sep;24(9):1511-2. doi: 10.1038/mt.2016.173. No abstract available.

PMID:
27687136
3.

Improving Adoptive T Cell Therapy: The Particular Role of T Cell Costimulation, Cytokines, and Post-Transfer Vaccination.

Redeker A, Arens R.

Front Immunol. 2016 Sep 6;7:345. doi: 10.3389/fimmu.2016.00345. Review.

4.

Potential use of lymph node-derived HPV-specific T cells for adoptive cell therapy of cervical cancer.

van Poelgeest MI, Visconti VV, Aghai Z, van Ham VJ, Heusinkveld M, Zandvliet ML, Valentijn AR, Goedemans R, van der Minne CE, Verdegaal EM, Trimbos JB, van der Burg SH, Welters MJ.

Cancer Immunol Immunother. 2016 Dec;65(12):1451-1463.

5.

Adoptive cell therapy and modulation of the tumour microenvironment: new insights from ASCO 2016.

Khoja L, Gyawali B.

Ecancermedicalscience. 2016 Sep 1;10:ed59. doi: 10.3332/ecancer.2016.ed59.

6.

Monitoring of the Immune Dysfunction in Cancer Patients.

Santegoets SJ, Welters MJ, van der Burg SH.

Vaccines (Basel). 2016 Sep 2;4(3). pii: E29. doi: 10.3390/vaccines4030029. Review.

7.

BET bromodomain inhibition enhances T cell persistence and function in adoptive immunotherapy models.

Kagoya Y, Nakatsugawa M, Yamashita Y, Ochi T, Guo T, Anczurowski M, Saso K, Butler MO, Arrowsmith CH, Hirano N.

J Clin Invest. 2016 Sep 1;126(9):3479-94. doi: 10.1172/JCI86437.

8.

MicroRNA-491 regulates the proliferation and apoptosis of CD8(+) T cells.

Yu T, Zuo QF, Gong L, Wang LN, Zou QM, Xiao B.

Sci Rep. 2016 Aug 3;6:30923. doi: 10.1038/srep30923.

9.

Role of IL-2 in cancer immunotherapy.

Jiang T, Zhou C, Ren S.

Oncoimmunology. 2016 Apr 25;5(6):e1163462. doi: 10.1080/2162402X.2016.1163462. Review.

PMID:
27471638
10.

Tumor relapse prevented by combining adoptive T cell therapy with Salmonella typhimurium.

Binder DC, Arina A, Wen F, Tu T, Zhao M, Hoffman RM, Wainwright DA, Schreiber H.

Oncoimmunology. 2016 Feb 18;5(6):e1130207. doi: 10.1080/2162402X.2015.1130207.

PMID:
27471609
11.

Harnessing the IL-7/IL-7Rα axis to improve tumor immunotherapy.

Johnson CB, Wrangle J, Mehrotra S, Li Z, Paulos CM, Cole DJ, Surh CD, Rubinstein MP.

Oncoimmunology. 2016 Jan 19;5(5):e1122865. doi: 10.1080/2162402X.2015.1122865.

PMID:
27467935
12.

Advances in immunotherapy for melanoma management.

Dany M, Nganga R, Chidiac A, Hanna E, Matar S, Elston D.

Hum Vaccin Immunother. 2016 Oct 2;12(10):2501-2511. doi: 10.1080/21645515.2016.1190889.

PMID:
27454404
13.

Effector, Memory, and Dysfunctional CD8(+) T Cell Fates in the Antitumor Immune Response.

Reiser J, Banerjee A.

J Immunol Res. 2016;2016:8941260. doi: 10.1155/2016/8941260. Review.

14.

Genetically Modified T-cell Therapy for the Treatment of Osteosarcoma: An Update.

DeRenzo C, Gottschalk S.

J Clin Cell Immunol. 2016 Apr;7(2). pii: 417. No abstract available.

PMID:
27313973
15.

CAR T Cell Therapy: A Game Changer in Cancer Treatment.

Almåsbak H, Aarvak T, Vemuri MC.

J Immunol Res. 2016;2016:5474602. doi: 10.1155/2016/5474602. Review.

16.

CAR models: next-generation CAR modifications for enhanced T-cell function.

Abate-Daga D, Davila ML.

Mol Ther Oncolytics. 2016 May 18;3:16014. doi: 10.1038/mto.2016.14. Review.

17.

Randomized, Prospective Evaluation Comparing Intensity of Lymphodepletion Before Adoptive Transfer of Tumor-Infiltrating Lymphocytes for Patients With Metastatic Melanoma.

Goff SL, Dudley ME, Citrin DE, Somerville RP, Wunderlich JR, Danforth DN, Zlott DA, Yang JC, Sherry RM, Kammula US, Klebanoff CA, Hughes MS, Restifo NP, Langhan MM, Shelton TE, Lu L, Kwong ML, Ilyas S, Klemen ND, Payabyab EC, Morton KE, Toomey MA, Steinberg SM, White DE, Rosenberg SA.

J Clin Oncol. 2016 Jul 10;34(20):2389-97. doi: 10.1200/JCO.2016.66.7220.

PMID:
27217459
18.

Immune Cells in Cancer Therapy and Drug Delivery.

Eyileten C, Majchrzak K, Pilch Z, Tonecka K, Mucha J, Taciak B, Ulewicz K, Witt K, Boffi A, Krol M, Rygiel TP.

Mediators Inflamm. 2016;2016:5230219. doi: 10.1155/2016/5230219. Review.

19.

Inflammatory Signals Regulate IL-15 in Response to Lymphodepletion.

Anthony SM, Rivas SC, Colpitts SL, Howard ME, Stonier SW, Schluns KS.

J Immunol. 2016 Jun 1;196(11):4544-52. doi: 10.4049/jimmunol.1600219.

PMID:
27183627
20.

IL-15 signaling promotes adoptive effector T-cell survival and memory formation in irradiation-induced lymphopenia.

Xu A, Bhanumathy KK, Wu J, Ye Z, Freywald A, Leary SC, Li R, Xiang J.

Cell Biosci. 2016 May 6;6:30. doi: 10.1186/s13578-016-0098-2.

Items per page

Supplemental Content

Support Center